Venus Concept Inc. (VERO)

CA — Healthcare Sector
Peers: AZYO  AIMD  SRDX  LNSR  IRIX  CVRX  INGN  OFIX  ESTA  NPCE  SGHT  SSKN  VAPO  TLIS  BBLG  BJDX  NUWE  HSCS  AXDX  ANIK  AXGN 

Automate Your Wheel Strategy on VERO

With Tiblio's Option Bot, you can configure your own wheel strategy including VERO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol VERO
  • Rev/Share 66.7898
  • Book/Share -10.2511
  • PB 0.7491
  • Debt/Equity 10.9054
  • CurrentRatio 1.2807
  • ROIC 1.7486

 

  • MktCap 3404316.0
  • FreeCF/Share -20.6361
  • PFCF -0.2327
  • PE -0.0342
  • Debt/Assets 1.3816
  • DivYield 0
  • ROE -10.7517

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
VERO
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants

Read More
image for news Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million
VERO
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today it has entered into a definitive agreement to sell its Venus Hair business to MHG Co. Ltd (“Meta Healthcare Group”) in an all-cash transaction valued at $20 million, subject to a customary working capital adjustment. The net proceeds from the transaction, once completed, will enhance the Company's balance sheet and financial condition and provide valuable capital to fund strategic growth initiatives.

Read More
image for news Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million
Venus Concept Inc. (VERO) Q1 2025 Earnings Call Transcript
VERO
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral

Venus Concept Inc. (NASDAQ:VERO ) Q1 2025 Earnings Conference Call May 15, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - CFO Conference Call Participants Thomas McGovern - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2025 Earnings Conference Call for Venus Concept Inc. At this time all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Read More
image for news Venus Concept Inc. (VERO) Q1 2025 Earnings Call Transcript
Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript
VERO
Published: March 31, 2025 by: Seeking Alpha
Sentiment: Neutral

Venus Concept Inc. (NASDAQ:VERO ) Q4 2024 Earnings Conference Call March 31, 2025 8:00 AM ET Company Participants Rajiv De Silva - CEO Domenic Della Penna - EVP and CFO Conference Call Participants Marie Thibault - BTIG Jeremy Pearlman - Maxim Group Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Venus Concept Inc. At this time, all participants have been placed in a listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay.

Read More
image for news Venus Concept Inc. (VERO) Q4 2024 Earnings Conference Call Transcript

About Venus Concept Inc. (VERO)

  • IPO Date 2017-10-12
  • Website https://www.venusconcept.com
  • Industry Medical - Devices
  • CEO Mr. Rajiv Kanishka Liyanaarchchie De Silva
  • Employees 292

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.